Skip to main content

Table 2 Characteristics of patients who had routine viral load tests done between 2014 and 2018

From: Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018

Variable

Category

N = (101,725)

Percentage (%)

Sex

Female

62,040

61.0

Male

36,915

36.3

Missing

2770

2.7

Median age IQR (Q1:Q3)

 

41(33–48)

 

Age

Children (0–9 years)

2544

2.5

Adolescents (10–19 years)

5048

5.0

Young adults (20–24 years)

3434

3.4

Adults (25–49 years)

65,449

64.3

Adults (≥ 50 years)

21,545

21.2

Missing

3705

3.6

Year of ART initiation

 < 2010

29,181

28.7

2011–2013

34,251

33.7

2014–2015

24,947

24.5

 > 2016

13,346

13.1

ART regimen

TDF based NNRTI

94,625

93.0

non-based TDF NNRTI

6759

6.6

PI Based

305

0.3

Other

36

 < 0.1

Pregnant

Confirmed

2695

2.6

Unconfirmed*

99,030

97.4

Breastfeeding

Confirmed

4579

4.5

Unconfirmed*

97,146

95.5

Consent to receive VL results notification via mobile text message reminder

Yes

76,550

75.3

No

19,297

19.0

Missing

5878

5.8

Level of care

Primary

65,564

64.5

Secondary

34,371

33.8

Tertiary

1657

1.6

Missing

133

0.1

  1. IQR interquartile range, TDF tenofovir, NNRTI non-nucleoside reverse transcriptase inhibitor, NRTI nucleoside reverse transcriptase inhibitor, PI protease inhibitor, VL viral load
  2. *Unconfirmed includes males and females of all ages